OcrelizumabPsychiatric syndrome: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1776卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70502-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：344 / 344

相关论文

共 50 条

[1] InfliximabSAPHO Syndrome: 2 case reports
Reactions Weekly, 2018, 1732 (1) : 205 - 205
[2] VancomycinDRESS syndrome: 2 case reports
Reactions Weekly, 2020, 1785 (1) : 487 - 487
[3] AntitubercularsDRESS syndrome: 2 case reports
Reactions Weekly, 2019, 1781 (1) : 61 - 61
[4] CytarabineCytarabine syndrome: 2 case reports
Reactions Weekly, 2015, 1549 (1) : 83 - 83
[5] IobitridolDRESS syndrome: 2 case reports
Reactions Weekly, 2021, 1862 (1) : 259 - 259
[6] AzathioprineHypersensitivity syndrome: 2 case reports
Reactions Weekly, 2021, 1861 (1) : 65 - 65
[7] SertralineSerotonin syndrome: 2 case reports
Reactions Weekly, 2021, 1857 (1) : 310 - 310
[8] AntimicrobialsDRESS syndrome: 2 case reports
Reactions Weekly, 2019, 1765 (1) : 35 - 35
[9] DapsoneHypersensitivity syndrome: 2 case reports
Reactions Weekly, 2012, 1394 (1) : 18 - 18
[10] FentanylChoreoathetotic syndrome: 2 case reports
Reactions Weekly, 2019, 1779 (1) : 114 - 114

← 1 2 3 4 5 →